Page last updated: 2024-10-31

nevirapine and Erythema

nevirapine has been researched along with Erythema in 3 studies

Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.

Erythema: Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes.

Research Excerpts

ExcerptRelevanceReference
"Risk for disease progression did not differ between the two groups (relative hazard of the triple-combination group, 1."2.68Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protoco ( Basgoz, N; D'Aquila, RT; Fischl, MA; Hirsch, MS; Hughes, MD; Johnson, VA; Liou, SH; Myers, M; Niu, M; Sommadossi, JP; Timpone, J, 1996)
"Nevirapine was dosed according to the manufacturer's guidelines."1.32Nevirapine use in HIV-1-infected children. ( Ball, C; Dumont, G; Gibb, DM; Lyall, H; Novelli, V; Sharland, M; Tudor-Williams, G; Verweel, G; Walters, S; Wilkins, E, 2003)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Verweel, G1
Sharland, M1
Lyall, H1
Novelli, V1
Gibb, DM1
Dumont, G1
Ball, C1
Wilkins, E1
Walters, S1
Tudor-Williams, G1
D'Aquila, RT1
Hughes, MD1
Johnson, VA1
Fischl, MA1
Sommadossi, JP1
Liou, SH1
Timpone, J1
Myers, M1
Basgoz, N1
Niu, M1
Hirsch, MS1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine[NCT00000770]Phase 2400 participants InterventionalCompleted
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for nevirapine and Erythema

ArticleYear
Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protoco
    Annals of internal medicine, 1996, Jun-15, Volume: 124, Issue:12

    Topics: Adult; CD4 Lymphocyte Count; Didanosine; Disease Progression; Double-Blind Method; Drug Therapy, Com

1996

Other Studies

2 other studies available for nevirapine and Erythema

ArticleYear
Nevirapine use in HIV-1-infected children.
    AIDS (London, England), 2003, Jul-25, Volume: 17, Issue:11

    Topics: Adolescent; Anti-HIV Agents; Body Height; CD4 Lymphocyte Count; Child; Child, Preschool; Cross-Secti

2003
Nevirapine triple combo results released.
    Common factor (Stoughton, Mass.), 1995, Issue:no 10

    Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; Drug Therapy, Combinat

1995